View drug registration information details.


ItemsRegistration information
ID672
No672
Brand NameMONTAIR TABLET 5 MG
IngredientsMONTELUKAST SODIUM EQ.TO MONTELUKAST 5 MG
Dosage FormCHEWABLE TABLET
Primary PackagingALU-ALU BLISTER
StorageSTORE BELOW 30 C
Shelf Life2 years
Pack SizeBOX OF 2 X 7'S
Dispensing CategoryPrescription only
ATC ClassificationXX
Pharmaceutical ClassLEUKOTRIEN RECEPTOR ANTAGONIST
IndicationsTREATMENT OF ASTHMA AS ADD-ON THERAPY IN THOSE 2-5 YEAR-OLD PATIENTS WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA. PROPHYLAXIS OF ASTHMA FROM 2 YEARS OF AGE AND OLDER IN WHICH THE PREDOMINANT COMPONENT IS EXCERCISED-INDUCED BRONCHOCONSTRICTION.
ContraindicationsHYPERSENSITIVITY
Side EffectsHEADACHE, INSOMNIA, ABDOMINAL PAIN, DIARRHEA, NAUSEA, VOMITING
Unit Price
EDL Yes
DescriptionLIGHT CHOCOLATE BROWN COLORED ROUND BICONVEX SHAPED TABLETS
Note
License OwnerEXAMED CO.,LTD
ManufacturerCCL PHARMACEUTICALS (PVT.) LTD.
CountryPAKISTAN
Import Registration No29951
Import Registration Date2007-04-16
ActivityCERTIFICATE RELEASED
Applied Date2022-11-11
FDD Registration No08 I 5593/23
FDD Registration Date2023-09-05
Expiry Date2026-09-04

Back to drug list